Apogee Therapeutics Statistics
Total Valuation
APGE has a market cap or net worth of $10.16 billion. The enterprise value is $8.88 billion.
| Market Cap | 10.16B |
| Enterprise Value | 8.88B |
Important Dates
The last earnings date was Monday, August 10, 2026, before market open.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
APGE has 75.42 million shares outstanding. The number of shares has increased by 17.59% in one year.
| Current Share Class | 61.93M |
| Shares Outstanding | 75.42M |
| Shares Change (YoY) | +17.59% |
| Shares Change (QoQ) | +8.29% |
| Owned by Insiders (%) | 1.85% |
| Owned by Institutions (%) | 78.48% |
| Float | 58.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.47 |
| P/TBV Ratio | 8.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 26.44, with a Debt / Equity ratio of 0.01.
| Current Ratio | 26.44 |
| Quick Ratio | 26.17 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -204.90 |
Financial Efficiency
Return on equity (ROE) is -32.46% and return on invested capital (ROIC) is -22.09%.
| Return on Equity (ROE) | -32.46% |
| Return on Assets (ROA) | -20.30% |
| Return on Invested Capital (ROIC) | -22.09% |
| Return on Capital Employed (ROCE) | -24.94% |
| Weighted Average Cost of Capital (WACC) | 6.15% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.13M |
| Employee Count | 261 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, APGE has paid $280,000 in taxes.
| Income Tax | 280,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +270.09% in the last 52 weeks. The beta is 0.34, so APGE's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +270.09% |
| 50-Day Moving Average | 127.36 |
| 200-Day Moving Average | 88.50 |
| Relative Strength Index (RSI) | 76.95 |
| Average Volume (20 Days) | 1,232,857 |
Short Selling Information
The latest short interest is 4.22 million, so 5.59% of the outstanding shares have been sold short.
| Short Interest | 4.22M |
| Short Previous Month | 4.13M |
| Short % of Shares Out | 5.59% |
| Short % of Float | 7.22% |
| Short Ratio (days to cover) | 2.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -323.75M |
| Pretax Income | -294.09M |
| Net Income | -294.37M |
| EBITDA | -322.12M |
| EBIT | -323.75M |
| Earnings Per Share (EPS) | -$4.34 |
Balance Sheet
The company has $971.93 million in cash and $6.83 million in debt, with a net cash position of $1.29 billion or $17.07 per share.
| Cash & Cash Equivalents | 971.93M |
| Total Debt | 6.83M |
| Net Cash | 1.29B |
| Net Cash Per Share | $17.07 |
| Equity (Book Value) | 1.19B |
| Book Value Per Share | 15.91 |
| Working Capital | 954.22M |
Cash Flow
In the last 12 months, operating cash flow was -$243.89 million and capital expenditures -$62,000, giving a free cash flow of -$243.96 million.
| Operating Cash Flow | -243.89M |
| Capital Expenditures | -62,000 |
| Depreciation & Amortization | 1.63M |
| Net Borrowing | n/a |
| Free Cash Flow | -243.96M |
| FCF Per Share | -$3.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.59% |
| Shareholder Yield | -17.59% |
| Earnings Yield | -2.90% |
| FCF Yield | -2.40% |
Analyst Forecast
The average price target for APGE is $134.85, which is 0.07% higher than the current price. The consensus rating is "Hold".
| Price Target | $134.85 |
| Price Target Difference | 0.07% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |